Testosterone, Free and Total, by Equilibrium Dialysis and Mass Spectrometry




Test Mnemonic

TESTTF

CPT Codes

  • 84402 - QTY (1)
  • 84403 - QTY (1)

LOINC ®

58952-3

Performing Laboratory

Cleveland Clinic Laboratories


Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
1.8 mLSerumRed Plain RefrigeratedAllow specimen to clot. Centrifuge and transfer the serum to a plastic CCL tube within 2 hours of collection and refrigerate.

Minimum Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
1 mL     

Stability

Environmental Condition Description
Refrigerated14 days
Ambient3 days
Frozen30 days

Turnaround Time

2 - 5 days

Methodology

Name Description
Equilibrium Dialysis 
Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) 

Reference Range

Free Testosterone
Sex Age From Age To Type Range Range Unit
Female  Days364 DaysNormal<0.10ng/dL
Female1 Years5 YearsNormal<0.10ng/dL
Female6 Years   Normal<0.10ng/dL
Female7 Years   Normal<0.10ng/dL
Female8 Years   Normal<= 0.14ng/dL
Female9 Years   Normal<= 0.18ng/dL
Female10 Years   Normal<= 0.24ng/dL
Female11 Years   Normal<= 0.29ng/dL
Female12 Years   Normal<= 0.34ng/dL
Female13 Years   Normal<= 0.38ng/dL
Female14 Years   Normal<= 0.42ng/dL
Female15 Years18 YearsNormal<= 0.44ng/dL
Female19 Years24 YearsNormal<= 0.43ng/dL
Female25 Years29 YearsNormal<= 0.42ng/dL
Female30 Years34 YearsNormal<= 0.41ng/dL
Female35 Years39 YearsNormal<= 0.40ng/dL
Female40 Years44 YearsNormal<= 0.39ng/dL
Female45 Years49 YearsNormal<= 0.38ng/dL
Female50 Years54 YearsNormal<= 0.37ng/dL
Female55 Years59 YearsNormal<= 0.36ng/dL
Female60 Years64 YearsNormal<= 0.35ng/dL
Female65 Years69 YearsNormal<= 0.34ng/dL
Female70 Years74 YearsNormal<= 0.33ng/dL
Female75 Years79 YearsNormal<= 0.32ng/dL
Female80 Years84 YearsNormal<= 0.30ng/dL
Female85 Years89 YearsNormal<= 0.29ng/dL
Female90 Years94 YearsNormal<= 0.28ng/dL
Female95 Years   Normal<= 0.27ng/dL
Male  Days364 DaysNormal<= 1.24ng/dL
Male1 Years8 YearsNormal<0.10ng/dL
Male9 Years   Normal<= 0.18ng/dL
Male10 Years   Normal<= 0.50ng/dL
Male11 Years   Normal<= 2.21ng/dL
Male12 Years   Normal<= 3.94ng/dL
Male13 Years   Normal<= 5.68ng/dL
Male14 Years   Normal0.19 - 7.09ng/dL
Male15 Years   Normal0.65 - 8.35ng/dL
Male16 Years   Normal1.17 - 9.29ng/dL
Male17 Years   Normal1.71 - 10.02ng/dL
Male18 Years   Normal2.16 - 10.49ng/dL
Male19 Years   Normal2.14 - 10.18ng/dL
Male20 Years24 YearsNormal2.10 - 9.92ng/dL
Male25 Years29 YearsNormal2.02 - 9.45ng/dL
Male30 Years34 YearsNormal1.94 - 9.03ng/dL
Male35 Years39 YearsNormal1.86 - 8.56ng/dL
Male40 Years44 YearsNormal1.78 - 8.03ng/dL
Male45 Years49 YearsNormal1.70 - 7.67ng/dL
Male50 Years54 YearsNormal1.62 - 7.25ng/dL
Male55 Years59 YearsNormal1.55 - 6.78ng/dL
Male60 Years64 YearsNormal1.47 - 6.36ng/dL
Male65 Years69 YearsNormal1.39 - 5.89ng/dL
Male70 Years74 YearsNormal1.31 - 5.47ng/dL
Male75 Years79 YearsNormal1.23 - 5.00ng/dL
Male80 Years84 YearsNormal1.15 - 4.58ng/dL
Male85 Years89 YearsNormal1.08 - 4.12ng/dL
Male90 Years94 YearsNormal1.00 - 3.67ng/dL
Male95 Years   Normal0.92 - 3.23ng/dL
Total Testosterone
Sex Age From Age To Type Range Range Unit
Female  Days14 DaysNormal1.7 - 13.4ng/dL
Female15 Days364 DaysNormal<= 6.3ng/dL
Female1 Years12 YearsNormal1.7 - 32.3ng/dL
Female13 Years15 YearsNormal14.4 - 39.2ng/dL
Female16 Years18 YearsNormal3.2 - 66.6ng/dL
Female19 Years   Normal8.0 - 60.0ng/dL
Male  Days14 DaysNormal7.2 - 183.0ng/dL
Male15 Days364 DaysNormal1.4 - 257.0ng/dL
Male1 Years12 YearsNormal1.7 - 32.3ng/dL
Male13 Years15 YearsNormal28.0 - 453.0ng/dL
Male16 Years18 YearsNormal27.7 - 674.0ng/dL
Male19 Years   Normal240.0 - 950.0ng/dL

Special Info

Free testosterone is directly measured after equilibrium dialysis by liquid-chromatography and tandem mass spectrometry (LC-MS/MS). 

Clinical Info

This test measures testosterone and direct free testosterone concentrations using liquid chromatography-tandem mass spectrometry (LC-MS/MS) and equilibrium dialysis (ED). It may be used to assess patients with suspected increased or decreased biologically active testosterone, including those with sex hormone-binding protein abnormalities, cisgender women, children, cisgender men with hypogonadism, and for monitoring patients on testosterone-suppressing therapy.

Clinical Limitation

Tanner Stage reference intervals are not yet established.Â